(Q74319408)
Statements
Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes (English)
Chowienczyk PJ
Brett SE
Gopaul NK
Meeking D
Marchetti M
Russell-Jones DL
Anggård EE